Cart
sales@molnova.com
5'-Fluoroindirubinoxime
CAS No. 861214-33-7
5'-Fluoroindirubinoxime( 5'-FIO )
Catalog No. M21594 CAS No. 861214-33-7
5'-Fluoroindirubinoxime is a potent FLT3 inhibitor( IC50 : 15 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 275 | In Stock |
|
| 50MG | 398 | In Stock |
|
| 100MG | 579 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5'-Fluoroindirubinoxime
-
NoteResearch use only, not for human use.
-
Brief Description5'-Fluoroindirubinoxime is a potent FLT3 inhibitor( IC50 : 15 nM).
-
Description5'-Fluoroindirubinoxime is a potent FLT3 inhibitor( IC50 : 15 nM).
-
In Vitro5'-Fluoroindirubinoxime (5’-FIO, compound 13) exhibits IC50 values of 1.53 μM and 1.27 μM for VEGFR2 and Aurora A, respectively.5'-Fluoroindirubinoxime (5’-FIO) exhibits IC50 values of 12.2 μM, 2.1 μM, 3.4 μM and 5.1 μM in A549, SNU-638, HT-1080 and RK3E-ras cancer cells, respectively. 5'-Fluoroindirubinoxime (5’-FIO) induces the apoptosis in RK3E-ras cells.
-
In Vivo5'-Fluoroindirubinoxime (5’-FIO, 10 μmol/L/100 μL (~2.95 mg/mL) every other day beginning on day 6, S.C..) exhibits significant anti-tumor activity in rats. Animal Model:Rat tumor model based RK3E-ras cells.Dosage:S.C..Administration:10 μmol/L/100 μL (~2.95 mg/mL) every other day beginning on day 6.Result:Effectively inhibited tumor growth.
-
Synonyms5'-FIO
-
PathwayAngiogenesis
-
TargetFLT
-
RecptorFLT3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number861214-33-7
-
Formula Weight295.27
-
Molecular FormulaC16H10FN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:83.33 mg/mL (282.22 mM; Need ultrasonic)
-
SMILESOc1[nH]c2ccc(F)cc2c1-c1[nH]c2ccccc2c1N=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim SA et al. Antitumor activity of novel indirubin derivatives in rat tumor model. Clin Cancer Res. 2007 Jan 1;13(1):253-9.
molnova catalog
related products
-
(E/Z)-Zotiraciclib
(E/Z)-Zotiraciclib inhibits CDK2, JAK2, and FLT3 effectively with IC50s of 13, 73, and 56 nM, respectively.
-
Merestinib dihydroch...
Merestinib dihydrochloride (LY2801653 dihydrochloride) is an orally available kinase inhibitor with antitumor activity that inhibits MET, AXL, RON, and MKNK1/2, and inhibits the growth of NTRK fusion-carrying tumors.
-
FLT3-IN-4
FLT3-IN-4 (FLT3 inhibitor 9u) is a potent and orally effective Fms-like tyrosine receptor kinase 3 (FLT3;?IC50=7 nM) inhibitor ,for treating acute myelogenous leukemia.
